Asia Pacific Infectious Disease In vitro Diagnostics Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Application (HIV or AIDS, Tuberculosis, Hepatitis B and C, Malaria, and Others) and End User (Hospitals and Clinics, Diagnostic Laboratories, Blood Bank, and Others)
The Asia Pacific Infectious Disease In Vitro Diagnostics (IVD) Market is projected to grow significantly, reaching an estimated US$ 19,641.4 million by 2031, up from US$ 11,030.6 million in 2024. This growth represents a compound annual growth rate (CAGR) of 8.6% from 2025 to 2031. The market encompasses various countries, including China, Japan, India, Australia, South Korea, and Malaysia, and is driven by several key factors.
The rise in infectious disease cases, advancements in technology, and increased research activities in biotechnology and biopharmaceuticals are primary drivers of this market expansion. The growing prevalence of infectious diseases, particularly in densely populated regions, has led to a heightened demand for effective diagnostic solutions. For instance, a report from ChinaTown Online indicates that around 15% of the Chinese population aged 15-49 is affected by sexually transmitted diseases, such as chlamydia and syphilis, which underscores the urgent need for advanced IVD products and services across the region.
Market Segmentation
The Asia Pacific Infectious Disease IVD Market is segmented by application and end-user. In terms of applications, the market includes categories such as HIV/AIDS, Tuberculosis, Hepatitis B and C, Malaria, and others. Notably, Hepatitis B and C are expected to hold the largest market share in 2024. Regarding end-users, the market is divided into Hospitals and Clinics, Diagnostic Laboratories, Blood Banks, and others, with Hospitals and Clinics also leading in market share for the same year.
Strategic Insights
Major players in the market, including Roche, Abbott, bioM?rieux, Thermo Fisher Scientific, Danaher (Cepheid), and Siemens Healthineers, are actively enhancing their global presence through partnerships, acquisitions, and innovative product development. For example, in August 2024, InBios International Inc. launched a new in vitro serological ELISA kit for the rapid diagnosis of Strongyloides infection, providing results in under 75 minutes. Additionally, Roche introduced its cobas Respiratory flex test in October 2024, capable of detecting 15 pathogens, including influenza and SARS-CoV-2, which is expected to improve diagnostic speed and laboratory efficiency.
These strategic developments are crucial for the growth of the infectious disease IVD market, as they include collaborations and mergers aimed at expanding product offerings and geographical reach. Companies are investing in research and development to launch advanced molecular and rapid diagnostic tests, enhancing their accuracy and turnaround times. Collaborations with government agencies and healthcare practitioners for large-scale screening and disease surveillance initiatives further bolster market growth.
Country Insights
The market is also analyzed by country, with China holding the largest share in 2024. The prevalence of infections such as HIV, hepatitis, urinary tract infections (UTIs), pneumonia, and respiratory infections in China is driving demand for antibiotics and antimycotics. According to the Epidemiology & Infection Journal 2023, approximately 21.1 million people in China suffer from community-acquired pneumonia annually. Furthermore, the World Health Organization (WHO) reports that there are about 87 million chronic carriers of the hepatitis B virus in China, representing a significant portion of the global burden of this disease. The need for effective management and treatment of these infections is critical for achieving global health targets.
The increasing number of strategic initiatives by market players, including product launches and developments, is expected to create substantial opportunities for market growth during the forecast period. For instance, in October 2024, Abbott launched its locally produced immunoassay module Alinity i at its Hangzhou site, marking a significant step in localized manufacturing of medical devices in China. Additionally, a collaboration between Shanghai Jiao Tong University and Zhejiang Orient Gene Biotech Co. Ltd. aims to develop a multi-index in vitro detection system using quantum dot liquid biochips, showcasing the innovative approaches being taken in the region.
Company Profiles
Key players in the Asia Pacific Infectious Disease IVD Market include Abbott Laboratories, F. Hoffmann-La Roche Ltd, Sysmex Corp, bioMerieux SA, Bio-Rad Laboratories Inc, QIAGEN NV, Bruker Corp, QuidelOrtho Corp, Becton, Dickinson and Co, and Danaher Corp. These companies are employing various strategies such as expansion, product innovation, and mergers and acquisitions to enhance their market presence and offer innovative solutions to consumers.
In summary, the Asia Pacific Infectious Disease IVD Market is poised for significant growth driven by increasing disease prevalence, technological advancements, and strategic initiatives by key players. The focus on improving diagnostic capabilities and expanding access to IVD products will be essential in addressing the rising health challenges in the region.
The rise in infectious disease cases, advancements in technology, and increased research activities in biotechnology and biopharmaceuticals are primary drivers of this market expansion. The growing prevalence of infectious diseases, particularly in densely populated regions, has led to a heightened demand for effective diagnostic solutions. For instance, a report from ChinaTown Online indicates that around 15% of the Chinese population aged 15-49 is affected by sexually transmitted diseases, such as chlamydia and syphilis, which underscores the urgent need for advanced IVD products and services across the region.
Market Segmentation
The Asia Pacific Infectious Disease IVD Market is segmented by application and end-user. In terms of applications, the market includes categories such as HIV/AIDS, Tuberculosis, Hepatitis B and C, Malaria, and others. Notably, Hepatitis B and C are expected to hold the largest market share in 2024. Regarding end-users, the market is divided into Hospitals and Clinics, Diagnostic Laboratories, Blood Banks, and others, with Hospitals and Clinics also leading in market share for the same year.
Strategic Insights
Major players in the market, including Roche, Abbott, bioM?rieux, Thermo Fisher Scientific, Danaher (Cepheid), and Siemens Healthineers, are actively enhancing their global presence through partnerships, acquisitions, and innovative product development. For example, in August 2024, InBios International Inc. launched a new in vitro serological ELISA kit for the rapid diagnosis of Strongyloides infection, providing results in under 75 minutes. Additionally, Roche introduced its cobas Respiratory flex test in October 2024, capable of detecting 15 pathogens, including influenza and SARS-CoV-2, which is expected to improve diagnostic speed and laboratory efficiency.
These strategic developments are crucial for the growth of the infectious disease IVD market, as they include collaborations and mergers aimed at expanding product offerings and geographical reach. Companies are investing in research and development to launch advanced molecular and rapid diagnostic tests, enhancing their accuracy and turnaround times. Collaborations with government agencies and healthcare practitioners for large-scale screening and disease surveillance initiatives further bolster market growth.
Country Insights
The market is also analyzed by country, with China holding the largest share in 2024. The prevalence of infections such as HIV, hepatitis, urinary tract infections (UTIs), pneumonia, and respiratory infections in China is driving demand for antibiotics and antimycotics. According to the Epidemiology & Infection Journal 2023, approximately 21.1 million people in China suffer from community-acquired pneumonia annually. Furthermore, the World Health Organization (WHO) reports that there are about 87 million chronic carriers of the hepatitis B virus in China, representing a significant portion of the global burden of this disease. The need for effective management and treatment of these infections is critical for achieving global health targets.
The increasing number of strategic initiatives by market players, including product launches and developments, is expected to create substantial opportunities for market growth during the forecast period. For instance, in October 2024, Abbott launched its locally produced immunoassay module Alinity i at its Hangzhou site, marking a significant step in localized manufacturing of medical devices in China. Additionally, a collaboration between Shanghai Jiao Tong University and Zhejiang Orient Gene Biotech Co. Ltd. aims to develop a multi-index in vitro detection system using quantum dot liquid biochips, showcasing the innovative approaches being taken in the region.
Company Profiles
Key players in the Asia Pacific Infectious Disease IVD Market include Abbott Laboratories, F. Hoffmann-La Roche Ltd, Sysmex Corp, bioMerieux SA, Bio-Rad Laboratories Inc, QIAGEN NV, Bruker Corp, QuidelOrtho Corp, Becton, Dickinson and Co, and Danaher Corp. These companies are employing various strategies such as expansion, product innovation, and mergers and acquisitions to enhance their market presence and offer innovative solutions to consumers.
In summary, the Asia Pacific Infectious Disease IVD Market is poised for significant growth driven by increasing disease prevalence, technological advancements, and strategic initiatives by key players. The focus on improving diagnostic capabilities and expanding access to IVD products will be essential in addressing the rising health challenges in the region.
1. INTRODUCTION
1.1 Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
2.2 Market Attractiveness
3. RESEARCH METHODOLOGY
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
4. ASIA PACIFIC INFECTIOUS DISEASE IN VITRO DIAGNOSTICS MARKET - KEY MARKET DYNAMICS
4.1 Market Drivers
4.2 Market Restraints
4.3 Market Opportunities
4.4 Future Trends
4.5 Impact of Drivers and Restraints:
5. INFECTIOUS DISEASE IN VITRO DIAGNOSTICS MARKET - ASIA PACIFIC MARKET ANALYSIS
5.1 Asia Pacific Infectious Disease In vitro Diagnostics Market Revenue (US$ Million), 2024 - 2031
5.2 Asia Pacific Infectious Disease In vitro Diagnostics Market Forecast and Analysis
6. ASIA PACIFIC INFECTIOUS DISEASE IN VITRO DIAGNOSTICS MARKET REVENUE ANALYSIS - BY APPLICATIONS
6.1 HIV or AIDS
6.1.1 Overview
6.1.2 HIV or AIDS: Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
6.2 Tuberculosis
6.2.1 Overview
6.2.2 Tuberculosis: Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
6.3 Hepatitis B and C
6.3.1 Overview
6.3.2 Hepatitis B and C: Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
6.4 Malaria
6.4.1 Overview
6.4.2 Malaria: Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
6.5 Others
6.5.1 Overview
6.5.2 Others: Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7. ASIA PACIFIC INFECTIOUS DISEASE IN VITRO DIAGNOSTICS MARKET REVENUE ANALYSIS - BY END USER
7.1 Hospitals and Clinics
7.1.1 Overview
7.1.2 Hospitals and Clinics: Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.2 Diagnostic Laboratories
7.2.1 Overview
7.2.2 Diagnostic Laboratories: Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.3 Blood Bank
7.3.1 Overview
7.3.2 Blood Bank: Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.4 Others
7.4.1 Overview
7.4.2 Others: Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8. ASIA PACIFIC INFECTIOUS DISEASE IN VITRO DIAGNOSTICS MARKET - COUNTRY ANALYSIS
8.1 Asia Pacific
8.1.1 Asia Pacific Infectious Disease In vitro Diagnostics Market Revenue and Forecast and Analysis - by Country
8.1.1.1 Asia Pacific Infectious Disease In vitro Diagnostics Market Revenue and Forecast and Analysis - by Country
8.1.2.2 China: Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.1.2.2.1 China: Asia Pacific Infectious Disease In vitro Diagnostics Market Share - by Applications
8.1.2.2.2 China: Asia Pacific Infectious Disease In vitro Diagnostics Market Share - by End User
8.2.3.3 Japan: Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.2.3.3.1 Japan: Asia Pacific Infectious Disease In vitro Diagnostics Market Share - by Applications
8.2.3.3.2 Japan: Asia Pacific Infectious Disease In vitro Diagnostics Market Share - by End User
8.3.4.4 India: Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.3.4.4.1 India: Asia Pacific Infectious Disease In vitro Diagnostics Market Share - by Applications
8.3.4.4.2 India: Asia Pacific Infectious Disease In vitro Diagnostics Market Share - by End User
8.4.5.5 Australia: Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.4.5.5.1 Australia: Asia Pacific Infectious Disease In vitro Diagnostics Market Share - by Applications
8.4.5.5.2 Australia: Asia Pacific Infectious Disease In vitro Diagnostics Market Share - by End User
8.5.6.6 South Korea: Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.5.6.6.1 South Korea: Asia Pacific Infectious Disease In vitro Diagnostics Market Share - by Applications
8.5.6.6.2 South Korea: Asia Pacific Infectious Disease In vitro Diagnostics Market Share - by End User
8.6.7.7 Rest of APAC: Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.6.7.7.1 Rest of APAC: Asia Pacific Infectious Disease In vitro Diagnostics Market Share - by Applications
8.6.7.7.2 Rest of APAC: Asia Pacific Infectious Disease In vitro Diagnostics Market Share - by End User
9 COMPETITIVE LANDSCAPE
9.1 Heat Map Analysis by Key Players
9.2 Company Positioning & Concentration
10 INDUSTRY LANDSCAPE
10.1 Overview
10.2 New Product Development
10.3 Merger and Acquisition
10.4 Other Strategic Developments
12 COMPANY PROFILES
11.1 Abbott Laboratories
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 F. Hoffmann-La Roche Ltd
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Sysmex Corp
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 bioMerieux SA
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Bio-Rad Laboratories Inc
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 QIAGEN NV
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Bruker Corp
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 QuidelOrtho Corp
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 Becton, Dickinson and Co
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 Danaher Corp
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Products and Services
11.10.4 Financial Overview
11.10.5 SWOT Analysis
11.10.6 Key Developments
12. APPENDIX
12.1 About The Insight Partners
1.1 Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
2.2 Market Attractiveness
3. RESEARCH METHODOLOGY
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
4. ASIA PACIFIC INFECTIOUS DISEASE IN VITRO DIAGNOSTICS MARKET - KEY MARKET DYNAMICS
4.1 Market Drivers
4.2 Market Restraints
4.3 Market Opportunities
4.4 Future Trends
4.5 Impact of Drivers and Restraints:
5. INFECTIOUS DISEASE IN VITRO DIAGNOSTICS MARKET - ASIA PACIFIC MARKET ANALYSIS
5.1 Asia Pacific Infectious Disease In vitro Diagnostics Market Revenue (US$ Million), 2024 - 2031
5.2 Asia Pacific Infectious Disease In vitro Diagnostics Market Forecast and Analysis
6. ASIA PACIFIC INFECTIOUS DISEASE IN VITRO DIAGNOSTICS MARKET REVENUE ANALYSIS - BY APPLICATIONS
6.1 HIV or AIDS
6.1.1 Overview
6.1.2 HIV or AIDS: Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
6.2 Tuberculosis
6.2.1 Overview
6.2.2 Tuberculosis: Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
6.3 Hepatitis B and C
6.3.1 Overview
6.3.2 Hepatitis B and C: Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
6.4 Malaria
6.4.1 Overview
6.4.2 Malaria: Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
6.5 Others
6.5.1 Overview
6.5.2 Others: Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7. ASIA PACIFIC INFECTIOUS DISEASE IN VITRO DIAGNOSTICS MARKET REVENUE ANALYSIS - BY END USER
7.1 Hospitals and Clinics
7.1.1 Overview
7.1.2 Hospitals and Clinics: Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.2 Diagnostic Laboratories
7.2.1 Overview
7.2.2 Diagnostic Laboratories: Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.3 Blood Bank
7.3.1 Overview
7.3.2 Blood Bank: Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.4 Others
7.4.1 Overview
7.4.2 Others: Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8. ASIA PACIFIC INFECTIOUS DISEASE IN VITRO DIAGNOSTICS MARKET - COUNTRY ANALYSIS
8.1 Asia Pacific
8.1.1 Asia Pacific Infectious Disease In vitro Diagnostics Market Revenue and Forecast and Analysis - by Country
8.1.1.1 Asia Pacific Infectious Disease In vitro Diagnostics Market Revenue and Forecast and Analysis - by Country
8.1.2.2 China: Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.1.2.2.1 China: Asia Pacific Infectious Disease In vitro Diagnostics Market Share - by Applications
8.1.2.2.2 China: Asia Pacific Infectious Disease In vitro Diagnostics Market Share - by End User
8.2.3.3 Japan: Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.2.3.3.1 Japan: Asia Pacific Infectious Disease In vitro Diagnostics Market Share - by Applications
8.2.3.3.2 Japan: Asia Pacific Infectious Disease In vitro Diagnostics Market Share - by End User
8.3.4.4 India: Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.3.4.4.1 India: Asia Pacific Infectious Disease In vitro Diagnostics Market Share - by Applications
8.3.4.4.2 India: Asia Pacific Infectious Disease In vitro Diagnostics Market Share - by End User
8.4.5.5 Australia: Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.4.5.5.1 Australia: Asia Pacific Infectious Disease In vitro Diagnostics Market Share - by Applications
8.4.5.5.2 Australia: Asia Pacific Infectious Disease In vitro Diagnostics Market Share - by End User
8.5.6.6 South Korea: Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.5.6.6.1 South Korea: Asia Pacific Infectious Disease In vitro Diagnostics Market Share - by Applications
8.5.6.6.2 South Korea: Asia Pacific Infectious Disease In vitro Diagnostics Market Share - by End User
8.6.7.7 Rest of APAC: Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.6.7.7.1 Rest of APAC: Asia Pacific Infectious Disease In vitro Diagnostics Market Share - by Applications
8.6.7.7.2 Rest of APAC: Asia Pacific Infectious Disease In vitro Diagnostics Market Share - by End User
9 COMPETITIVE LANDSCAPE
9.1 Heat Map Analysis by Key Players
9.2 Company Positioning & Concentration
10 INDUSTRY LANDSCAPE
10.1 Overview
10.2 New Product Development
10.3 Merger and Acquisition
10.4 Other Strategic Developments
12 COMPANY PROFILES
11.1 Abbott Laboratories
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 F. Hoffmann-La Roche Ltd
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Sysmex Corp
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 bioMerieux SA
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Bio-Rad Laboratories Inc
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 QIAGEN NV
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Bruker Corp
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 QuidelOrtho Corp
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 Becton, Dickinson and Co
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 Danaher Corp
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Products and Services
11.10.4 Financial Overview
11.10.5 SWOT Analysis
11.10.6 Key Developments
12. APPENDIX
12.1 About The Insight Partners
LIST OF TABLES
Table 1. Asia Pacific Infectious Disease In vitro Diagnostics Market Segmentation
Table 3. Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Table 4. Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Applications
Table 5. Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 6. Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Country
Table 7. China: Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Applications
Table 8. China: Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 9. Japan: Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Applications
Table 10. Japan: Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 11. India: Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Applications
Table 12. India: Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 13. Australia: Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Applications
Table 14. Australia: Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 15. South Korea: Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Applications
Table 16. South Korea: Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 17. Rest of APAC: Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Applications
Table 18. Rest of APAC: Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 19. Heat Map Analysis by Key Players
Table 1. Asia Pacific Infectious Disease In vitro Diagnostics Market Segmentation
Table 3. Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Table 4. Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Applications
Table 5. Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 6. Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Country
Table 7. China: Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Applications
Table 8. China: Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 9. Japan: Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Applications
Table 10. Japan: Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 11. India: Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Applications
Table 12. India: Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 13. Australia: Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Applications
Table 14. Australia: Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 15. South Korea: Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Applications
Table 16. South Korea: Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 17. Rest of APAC: Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Applications
Table 18. Rest of APAC: Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 19. Heat Map Analysis by Key Players
LIST OF FIGURES
Figure 1. Asia Pacific Infectious Disease In vitro Diagnostics Market Segmentation - Country
Figure 4. Asia Pacific Infectious Disease In vitro Diagnostics Market - Key Market Dynamics
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. Asia Pacific Infectious Disease In vitro Diagnostics Market Revenue (US$ Million), 2024 - 2031
Figure 7. Asia Pacific Infectious Disease In vitro Diagnostics Market Share (%) - by Applications, 2024 and 2031
Figure 8. HIV or AIDS: Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 9. Tuberculosis: Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 10. Hepatitis B and C: Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 11. Malaria: Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 12. Others: Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 13. Asia Pacific Infectious Disease In vitro Diagnostics Market Share (%) - by End User, 2024 and 2031
Figure 14. Hospitals and Clinics: Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 15. Diagnostic Laboratories: Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 16. Blood Bank: Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 17. Others: Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 18. Asia Pacific Infectious Disease In vitro Diagnostics Market Breakdown by Key Countries, 2024 and 2031 (%)
Figure 19. China: Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 20. Japan: Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 21. India: Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 22. Australia: Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 23. South Korea: Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 24. Rest of APAC: Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 25. Company Positioning & Concentration
Figure 1. Asia Pacific Infectious Disease In vitro Diagnostics Market Segmentation - Country
Figure 4. Asia Pacific Infectious Disease In vitro Diagnostics Market - Key Market Dynamics
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. Asia Pacific Infectious Disease In vitro Diagnostics Market Revenue (US$ Million), 2024 - 2031
Figure 7. Asia Pacific Infectious Disease In vitro Diagnostics Market Share (%) - by Applications, 2024 and 2031
Figure 8. HIV or AIDS: Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 9. Tuberculosis: Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 10. Hepatitis B and C: Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 11. Malaria: Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 12. Others: Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 13. Asia Pacific Infectious Disease In vitro Diagnostics Market Share (%) - by End User, 2024 and 2031
Figure 14. Hospitals and Clinics: Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 15. Diagnostic Laboratories: Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 16. Blood Bank: Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 17. Others: Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 18. Asia Pacific Infectious Disease In vitro Diagnostics Market Breakdown by Key Countries, 2024 and 2031 (%)
Figure 19. China: Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 20. Japan: Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 21. India: Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 22. Australia: Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 23. South Korea: Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 24. Rest of APAC: Asia Pacific Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 25. Company Positioning & Concentration
